- Home
- ANIP vs STAA Comparison
ANIP vs STAA Comparison
Compare ANIP & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- STAA
- Stock Information
- Founded
- ANIP 2001
- STAA 1982
- Country
- ANIP United States
- STAA United States
- Employees
- ANIP N/A
- STAA N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- ANIP Health Care
- STAA Health Care
- Exchange
- ANIP Nasdaq
- STAA Nasdaq
- Market Cap
- ANIP 1.2B
- STAA 1.1B
- IPO Year
- ANIP N/A
- STAA N/A
- Fundamental
- Price
- ANIP $58.46
- STAA $22.29
- Analyst Decision
- ANIP Buy
- STAA Buy
- Analyst Count
- ANIP 7
- STAA 7
- Target Price
- ANIP $77.33
- STAA $42.83
- AVG Volume (30 Days)
- ANIP 254.4K
- STAA 656.2K
- Earning Date
- ANIP 02-27-2025
- STAA 02-19-2025
- Dividend Yield
- ANIP N/A
- STAA N/A
- EPS Growth
- ANIP N/A
- STAA 9.97
- EPS
- ANIP N/A
- STAA 0.44
- Revenue
- ANIP $555,456,000.00
- STAA $341,224,000.00
- Revenue This Year
- ANIP $25.48
- STAA $8.37
- Revenue Next Year
- ANIP $20.24
- STAA $10.55
- P/E Ratio
- ANIP N/A
- STAA $50.67
- Revenue Growth
- ANIP 23.60
- STAA 10.01
- 52 Week Low
- ANIP $52.50
- STAA $21.13
- 52 Week High
- ANIP $70.81
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- ANIP 62.05
- STAA 37.11
- Support Level
- ANIP $52.74
- STAA $21.25
- Resistance Level
- ANIP $55.21
- STAA $22.78
- Average True Range (ATR)
- ANIP 1.54
- STAA 1.15
- MACD
- ANIP 0.48
- STAA -0.07
- Stochastic Oscillator
- ANIP 98.11
- STAA 27.17
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.